Phosphoinositide 3-Kinase in Health and Disease: Volume 1

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here we give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here

• Format: Paperback
• Language: English
• ISBN: 3642265227
• ISBN13: 9783642265228
• Release Date: November 2012
• Publisher: Springer
• Length: 310 Pages
• Weight: 1.00 lbs.
• Dimensions: 0.9" x 6.1" x 9.1"